Literature DB >> 29129805

Rare genetic diseases: update on diagnosis, treatment and online resources.

Robert E Pogue1, Denise P Cavalcanti2, Shreya Shanker3, Rosangela V Andrade4, Lana R Aguiar4, Juliana L de Carvalho5, Fabrício F Costa6.   

Abstract

Rare genetic diseases collectively impact a significant portion of the world's population. For many diseases there is limited information available, and clinicians can find difficulty in differentiating between clinically similar conditions. This leads to problems in genetic counseling and patient treatment. The biomedical market is affected because pharmaceutical and biotechnology industries do not see advantages in addressing rare disease treatments, or because the cost of the treatments is too high. By contrast, technological advances including DNA sequencing and analysis, together with computer-aided tools and online resources, are allowing a more thorough understanding of rare disorders. Here, we discuss how the collection of various types of information together with the use of new technologies is facilitating diagnosis and, consequently, treatment of rare diseases.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 29129805     DOI: 10.1016/j.drudis.2017.11.002

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  12 in total

Review 1.  Current Drug Repurposing Strategies for Rare Neurodegenerative Disorders.

Authors:  Sweta Shah; Marc Marie Dooms; Sofia Amaral-Garcia; Mariana Igoillo-Esteve
Journal:  Front Pharmacol       Date:  2021-12-21       Impact factor: 5.810

2.  Epidemiology of rare diseases in Brazil: protocol of the Brazilian Rare Diseases Network (RARAS-BRDN).

Authors:  Têmis Maria Félix; Bibiana Mello de Oliveira; Milena Artifon; Isabelle Carvalho; Filipe Andrade Bernardi; Ida V D Schwartz; Jonas A Saute; Victor E F Ferraz; Angelina X Acosta; Ney Boa Sorte; Domingos Alves
Journal:  Orphanet J Rare Dis       Date:  2022-02-24       Impact factor: 4.123

3.  Patient-driven initiatives for prioritizing drug discovery for rare diseases.

Authors:  Alok Bhattacharya; Sudha Bhattacharya
Journal:  Indian J Med Res       Date:  2019-03       Impact factor: 2.375

Review 4.  Extensive eye-oral-bronchial mucosal nodules with eosinopgillia: a rare case report and literature review.

Authors:  Lujin Wu; Qianru Leng; Yan Wang; Daowen Wang; Danlei Yang
Journal:  BMC Pulm Med       Date:  2020-11-12       Impact factor: 3.317

5.  An Ethics Framework for Big Data in Health and Research.

Authors:  Vicki Xafis; G Owen Schaefer; Markus K Labude; Iain Brassington; Angela Ballantyne; Hannah Yeefen Lim; Wendy Lipworth; Tamra Lysaght; Cameron Stewart; Shirley Sun; Graeme T Laurie; E Shyong Tai
Journal:  Asian Bioeth Rev       Date:  2019-10-01

6.  Rare disorders have many faces: in silico characterization of rare disorder spectrum.

Authors:  Simona D Frederiksen; Vladimir Avramović; Tatiana Maroilley; Anna Lehman; Laura Arbour; Maja Tarailo-Graovac
Journal:  Orphanet J Rare Dis       Date:  2022-02-22       Impact factor: 4.123

7.  Dose-finding studies in drug development for rare genetic diseases.

Authors:  Lingshan Wang; Jie Wang; Ji Feng; Mary Doi; Salvatore Pepe; Michael Pacanowski; Robert N Schuck
Journal:  Orphanet J Rare Dis       Date:  2022-04-05       Impact factor: 4.123

8.  Agonists of prostaglandin E2 receptors as potential first in class treatment for nephronophthisis and related ciliopathies.

Authors:  Hugo Garcia; Alice S Serafin; Flora Silbermann; Esther Porée; Amandine Viau; Clémentine Mahaut; Katy Billot; Éléonore Birgy; Meriem Garfa-Traore; Stéphanie Roy; Salomé Ceccarelli; Manon Mehraz; Pamela C Rodriguez; Bérangère Deleglise; Laetitia Furio; Fabienne Jabot-Hanin; Nicolas Cagnard; Elaine Del Nery; Marc Fila; Soraya Sin-Monnot; Corinne Antignac; Stanislas Lyonnet; Pauline Krug; Rémi Salomon; Jean-Philippe Annereau; Alexandre Benmerah; Marion Delous; Luis Briseño-Roa; Sophie Saunier
Journal:  Proc Natl Acad Sci U S A       Date:  2022-04-28       Impact factor: 12.779

Review 9.  How Machine Learning and Statistical Models Advance Molecular Diagnostics of Rare Disorders Via Analysis of RNA Sequencing Data.

Authors:  Lea D Schlieben; Holger Prokisch; Vicente A Yépez
Journal:  Front Mol Biosci       Date:  2021-06-01

Review 10.  Contribution of Human Pluripotent Stem Cell-Based Models to Drug Discovery for Neurological Disorders.

Authors:  Alexandra Benchoua; Marie Lasbareilles; Johana Tournois
Journal:  Cells       Date:  2021-11-24       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.